TMED Holdings — T. Rowe Price Health Care ETF
All 99 reported holdings of T. Rowe Price Health Care ETF (TMED) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co. | 16.71% | $3.85M |
| Unitedhealth Group, Inc. | 6.52% | $1.50M |
| Gilead Sciences, Inc. | 4.43% | $1.02M |
| Thermo Fisher Scientific, Inc. | 4.11% | $947.57K |
| Danaher Corp. | 2.96% | $681.92K |
| Cencora, Inc. | 2.75% | $633.88K |
| Agilent Technologies, Inc. | 2.61% | $601.72K |
| Alnylam Pharmaceuticals, Inc. | 2.60% | $597.85K |
| Intuitive Surgical, Inc. | 2.43% | $560.73K |
| Insulet Corp. | 2.38% | $548.25K |
| Stryker Corp. | 2.22% | $511.30K |
| Dyne Therapeutics, Inc. | 2.03% | $467.94K |
| Elanco Animal Health, Inc. | 1.91% | $439.63K |
| Pfizer, Inc. | 1.91% | $438.93K |
| Cytokinetics, Inc. | 1.69% | $388.81K |
| Waters Corp. | 1.68% | $387.79K |
| West Pharmaceutical Services | 1.65% | $380.54K |
| Ascendis Pharma A/s | 1.60% | $368.61K |
| Biogen, Inc. | 1.55% | $357.36K |
| Mckesson Corp. | 1.46% | $335.49K |
| Dexcom, Inc. | 1.46% | $335.13K |
| Immunome, Inc. | 1.38% | $318.04K |
| Biontech SE-ADR | 1.29% | $296.64K |
| Humana, Inc. | 1.24% | $286.40K |
| Denali Therapeutics, Inc. | 1.22% | $281.94K |
| Cvs Health Corp. | 1.22% | $281.07K |
| Idexx Laboratories, Inc. | 1.18% | $271.12K |
| Vaxcyte, Inc. | 1.18% | $270.60K |
| Mettler-Toledo International | 0.97% | $222.29K |
| Hca Healthcare, Inc. | 0.95% | $219.12K |
| Immatics NV | 0.87% | $199.78K |
| Repligen Corp. | 0.85% | $195.11K |
| Elevance Health, Inc. | 0.77% | $176.35K |
| Shattuck Labs, Inc. | 0.76% | $175.92K |
| Apogee Therapeutics, Inc. | 0.75% | $173.74K |
| State Street Ins US Go Mm Fd-Is | 0.73% | $169.17K |
| Becton Dickinson And Co. | 0.72% | $166.16K |
| Moonlake Immunotherapeutics | 0.66% | $152.31K |
| Cooper Cos Inc/the | 0.65% | $149.73K |
| Cabaletta Bio, Inc. | 0.62% | $142.00K |
| Cg Oncology, Inc. | 0.62% | $141.82K |
| Tenet Healthcare Corp. | 0.56% | $129.65K |
| Bicara Therapeutics, Inc. | 0.53% | $121.82K |
| Alignment Healthcare, Inc. | 0.50% | $115.24K |
| Sarepta Therapeutics, Inc. | 0.47% | $109.04K |
| Kymera Therapeutics, Inc. | 0.47% | $108.82K |
| Revvity, Inc. | 0.45% | $103.03K |
| Adaptive Biotechnologies | 0.42% | $96.07K |
| Molina Healthcare, Inc. | 0.41% | $95.14K |
| Beone Medicines Ltd.-ADR | 0.40% | $91.76K |
| Maplight Therapeutics, Inc. | 0.40% | $91.14K |
| Akeso, Inc. | 0.39% | $90.08K |
| Kodiak Sciences, Inc. | 0.36% | $83.65K |
| Genedx Holdings Corp. | 0.36% | $82.38K |
| Dianthus Therapeutics, Inc. | 0.35% | $79.54K |
| Avalo Therapeutics, Inc. | 0.34% | $79.22K |
| Incyte Corp. | 0.33% | $75.84K |
| 4d Molecular Therapeutics In | 0.32% | $73.75K |
| Xenon Pharmaceuticals, Inc. | 0.32% | $73.40K |
| Novocure Ltd. | 0.31% | $72.17K |
| Eikon Therapeutics, Inc. | 0.31% | $72.06K |
| Oruka Therapeutics, Inc. | 0.31% | $71.00K |
| Stoke Therapeutics, Inc. | 0.31% | $70.90K |
| Onkure Therapeutics, Inc. | 0.30% | $69.93K |
| Stevanato Group Spa | 0.30% | $69.91K |
| Sartorius AG | 0.30% | $68.73K |
| Caris Life Sciences, Inc. | 0.29% | $65.83K |
| Kardigan, Inc. | 0.28% | $64.28K |
| Crinetics Pharmaceuticals In | 0.26% | $59.72K |
| Grail, Inc. | 0.26% | $59.26K |
| Arcus Biosciences, Inc. | 0.25% | $57.59K |
| Maze Therapeutics, Inc. | 0.21% | $49.42K |
| Aktis Oncology, Inc. | 0.21% | $48.89K |
| Allogene Therapeutics, Inc. | 0.21% | $48.15K |
| Oric Pharmaceuticals, Inc. | 0.21% | $47.44K |
| Rapport Therapeutics, Inc. | 0.20% | $46.96K |
| Amylyx Pharmaceuticals, Inc. | 0.20% | $46.89K |
| Spyre Therapeutics Inc | 0.20% | $46.61K |
| Damora Therapeutics Inc | 0.20% | $46.51K |
| Enliven Therapeutics, Inc. | 0.20% | $45.22K |
| Procept Biorobotics Corp. | 0.19% | $44.05K |
| Disc Medicine, Inc. | 0.19% | $43.88K |
| Avalyn Pharma, Inc. | 0.18% | $40.95K |
| Ionis Pharmaceuticals, Inc. | 0.18% | $40.36K |
| Schrodinger, Inc. | 0.16% | $36.34K |
| Black Diamond Therapeutics I | 0.12% | $28.23K |
| Abivax SA-ADR | 0.12% | $27.85K |
| Erasca, Inc. | 0.12% | $26.75K |
| Personalis, Inc. | 0.12% | $26.67K |
| Karyopharm Therapeutics, Inc. | 0.10% | $24.13K |
| Prime Medicine, Inc. | 0.10% | $22.70K |
| Immunovant, Inc. | 0.10% | $22.35K |
| Biohaven Ltd. | 0.09% | $21.70K |
| Crispr Therapeutics AG | 0.09% | $20.78K |
| Annexon, Inc. | 0.05% | $11.92K |
| Metsera, Inc. Cvr | 0.00% | $0 |
| Applied Therapeutics, Inc. Cvr | 0.00% | $0 |
| Centessa Pharmaceuticals-ADR Cvr | 0.00% | $0 |
TMED overview: performance, fees, allocation and SEC filings